云南白药品牌怎么样 申请店铺

我要投票 云南白药在保健养生行业中的票数:585 更新时间:2025-05-18
云南白药是哪个国家的品牌?「云南白药」是 云南白药集团股份有限公司 旗下著名品牌。该品牌发源于云南省昆明市,由创始人王明辉在1993-11-30期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力云南白药品牌出海!将品牌入驻外推网,定制云南白药品牌推广信息,可以显著提高云南白药产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

云南白药怎么样

云南白药由云南民间名医曲焕章先生于1902年创制,问世百年来,以其神奇的疗效被世人誉之为“伤科圣药”、“中华瑰宝”。

1971年,公司前身云南白药厂正式成立,白药开始了专业化生产。公司于1993年在深交所挂牌上市,成为云南省第一家A股上市公司。1996年,公司分别投资控股原云南地州的三家云南白药生产企业,即云南大理州制药厂、云南文山州制药厂和云南丽江药业有限公司,共同组成云南白药集团,对云南白药的生产经营实行“五统一”,为名牌战略的实施奠定了基础。1997年公司经国家批准获得自营进出口权。1999年,红塔成为白药集团第二大股东,实现了股权多元化;同年,云南省医药公司和天紫红药厂以优质资产配股方式进入云南白药集团,集团产业链从生产制造延伸到了药品流通和饮片加工领域。目前,省医药公司已成功改组为云南省医药有限公司,在云南首家通过国家GSP认证。天紫红药厂已改制为云南白药集团原生药材事业部,作为省内唯一的饮片加工企业,已于2003年顺利通过国家GMP认证。

经过30多年的发展,公司已从一个资产不足300万元的生产企业成长为一个总资产22亿多,总销售收入逾32亿元,经营涉及化学原料药、化学药制剂、中成药、中药材、生物制品、保健食品、化妆品及饮料的研制、生产及销售;糖、茶,建筑材料,装饰材料的批发、零售、代购代销;科技及经济技术咨询服务,医疗器械(二类、医用敷料类、一次性使用医疗卫生用品),日化用品等领域的云南省实力最强、品牌最优的大型医药企业集团。公司产品以云南白药系列和田七系列为主,共十种剂型七十余个产品,主要销往国内、港澳、东南亚等地区,并已进入日本、欧美等国家、地区的市场。“云南白药”商标于2002年2月被国家工商行政管理总局商标局评为中国驰名商标。

Yunnan Baiyao was created in 1902 by Mr. Qu Huanzhang, a famous folk doctor in Yunnan Province. It has been known as "the holy medicine of Traumatology" and "the treasure of China" for its magical curative effect for more than 100 years. In 1971, Yunnan Baiyao factory, the predecessor of the company, was officially established and specialized production of Baiyao began. The company was listed on Shenzhen Stock Exchange in 1993 and became the first A-share listed company in Yunnan Province. In 1996, the company invested and controlled three Yunnan Baiyao production enterprises in the former Yunnan Prefecture, namely Yunnan Dalizhou pharmaceutical factory, Yunnan Wenshanzhou pharmaceutical factory and Yunnan Lijiang Pharmaceutical Co., Ltd. to jointly form Yunnan Baiyao group, which implemented "Five Unifications" for the production and operation of Yunnan Baiyao, laying a foundation for the implementation of the famous brand strategy. In 1997, the company obtained the right of self import and export with the approval of the state. In 1999, Hongta became the second largest shareholder of Baiyao group, realizing equity diversification; in the same year, Yunnan pharmaceutical company and Tianzi Hongyao factory entered Yunnan Baiyao group by way of high-quality asset allotment, and the industrial chain of the group extended from production and manufacturing to the field of drug circulation and processing of decoction pieces. At present, the provincial pharmaceutical company has been successfully restructured into Yunnan Pharmaceutical Co., Ltd., the first one in Yunnan to pass the national GSP certification. Tianzihong pharmaceutical factory has been transformed into Yunnan Baiyao Group's original medicine business department. As the only processing enterprise in the province, it has successfully passed the national GMP certification in 2003. After more than 30 years of development, the company has grown from a production enterprise with less than 3 million yuan of assets to a total asset of more than 2.2 billion yuan, with a total sales revenue of more than 3.2 billion yuan. Its business involves the research, production and sales of chemical raw materials, chemical pharmaceutical preparations, Chinese patent medicines, biological products, health food, cosmetics and drinks; It is a large pharmaceutical enterprise group with the strongest strength and the best brand in Yunnan Province in the fields of sugar, tea, building materials, decoration materials wholesale, retail, purchasing and selling on behalf of others; scientific and technological and economic and technological consulting services, medical devices (class II, medical dressings, disposable medical and health products), daily chemical products, etc. The company's products are mainly Yunnan Baiyao series and Tianqi series, with a total of more than 70 dosage forms, which are mainly sold to domestic, Hong Kong, Macao, Southeast Asia and other regions, and have entered the markets of Japan, Europe and the United States and other countries and regions. "Yunnan Baiyao" trademark was awarded as China's well-known trademark by the Trademark Office of the State Administration for Industry and Commerce in February 2002.

本文链接: https://brand.waitui.com/7cc1e882e.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

哈尔滨市19日启动“国补”家装消费品焕新活动

哈尔滨市将于5月19日正式启动“国补2025年家装消费品(家装建材领域)焕新活动”。本次活动补贴覆盖装修材料、卫生洁具、家具照明三大品类53小类产品。消费者购买符合条件产品,按剔除折扣后最终售价的15%享受立减补贴;购买1级能效或水效标准商品,补贴比例提升至20%。每位消费者每类产品限补贴1笔,单笔补贴不超过2000元,活动期间累计最高补贴15000元。(21财经)

2小时前

中信证券:市场对于公募考核新规以及回归基准行业配置的讨论存在一些误区

36氪获悉,中信证券研报认为,市场对于公募考核新规以及回归基准行业配置的讨论存在一些误区。从海外经验来看,回归基准是通过基准的行业配比向基金持仓配比演化而不是相反;产品投资策略向客户盈利导向回归,在长期视野下,这与追求排名和绝对收益并不矛盾,反而是统一的;跑输基准的惩罚机制最终导致的是基金减少博弈性持仓,长期来看最大的影响是活跃头寸的占比下降。

2小时前

如何把握并购重组的投资机遇?中金:重点关注四个方面

36氪获悉,中金公司研究部首席国内策略分析师李求索表示,重点关注四个方面的投资方向。一是科创龙头做优做强,本轮并购重组政策将对科技创新企业进一步加大支持力度。二是传统板块的产业整合趋势,结合历史数据,行业集中度偏低的领域,企业并购重组意愿相对较强。三是新形势下国央企市值管理意愿有望提升,并购重组作为市值管理的重要方向之一,从国央企的角度边际意愿有望增加。四是未上市企业的多元选择,近年在IPO环境变化背景下,不少未上市公司也选择并购重组作为公司方向性考量。

2小时前

河北医保基金即时结算超20亿元

据国家医保局消息,医保基金是群众看病就医的“保命钱”,也是医疗服务和医药产品的重要资金来源,即时结算是今年医保改革的重要举措。河北省省市县(区)医保部门全面开展即时结算改革工作,定点医药机构医保费用日日有回款。截至5月8日,累计向18413家定点医药机构拨付医保基金20.17亿元。(21财经)

2小时前

天问二号探测器顺利转入发射区,计划5月底择机发射

来自国家航天局的消息,5月18日,行星探测工程天问二号探测器在西昌卫星发射中心按计划完成技术区总装、测试、加注等工作后,顺利转入发射区,后续将按计划开展各项功能检查、联合测试等工作,计划5月底择机实施发射。天问二号任务将通过一次发射,实施小行星2016HO3伴飞、取样、返回和主带彗星311P伴飞探测等多项任务。(央视新闻)

2小时前

本页详细列出关于云南白药的品牌信息,含品牌所属公司介绍,云南白药所处行业的品牌地位及优势。
咨询